Volume 1 Issue 1 will be published in June, 2023   A sister journal of The Innovation
Jie Qiao
Prof. in Gynecology & Obstetrics
Peking University
Academician of the Chinese Academy of Engineering
Table of Contents
View Archive >
The Innovation Medicine: An international journal of medical science
Ji Dai et al.
Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome?
Huiyu Xu et al.
Pushing the boundary of cancer diagnostics through microfluidic technologies
Ada Hang-Heng Wong
Lilly's Donanemab, will it be the light at the end of the tunnel?
Jianhong Dong et al.
Aims & Scope

The Innovation Medicine is a sister journal of The Innovation. It is expected to influence clinical decision for both better patient care and better continuing medical education, aiming to have an impact in world health community. The Innovation Medicine is an international general medical journal via Open Access, publishing innovative, rigorous and cutting-edge progress in medical science, especially in multidisciplinary co-operation achievements. After publishing, your works will go to global reach and visibility, which is supposed to educate this journal’s audience.

The Innovation Medicine welcome submission of original works from any branches of medicine that advance medical science or clinical practice, including but not limited to:

1. Aging
2. Basic medicine
3. Cardiovascular disease
4. Clinical trials (Phase 1, 2, 3 or 4)
5. Gene therapy or cell therapy or self-definition therapy
6. Global health issues
7. Human microbiome
8. Infectious diseases
9. Medical imaging
10. Medical immunology
11. Neurology and psychiatry
12. Oncology
13. Physiology and pathology
14. Public health study and policy
15. Regenerative medicine
16. Translational medicine
17. MedicineX (multidisciplinary collaboration): artificial intelligence in healthcare, smart wearable devices, et al.

Inaugural Words

The Innovation Medicine: An international journal of medical science

Back to spring of 2020, when the World Health Organization declared the novel coronavirus (COVID-19) outbreak a global pandemic, we were more than ever to aware of the fact that we live in a community with a shared future of mankind. Three years later, as most regions on this planet slowly begin to emerge from the darkness, we look back on the footprints we have left behind and wonder what the most powerful weapon is to combat such a global threat. Without hesitation, the answer pops out immediately:

Medicine. Medicine explains us why a virus makes people sick, how to treat such a disease, and how to develop vaccines and drugs to protect us. Aside from COVID-19, we cannot predict which pandemic will appear in the next 50 or 100 years, yet we are certain that medicine will keep advancing as it has been done in the past.

The history of medicine mirrors the history of human civilization. Early medicine germinates from ancient civilizations, from which the oldest and most widely known treatise on medical ethics–The Hippocratic Oath–was developed and is still taking effect nowadays. The discovery of the circulatory system and the invention of microscopes transferred medicine from Humorism to the Germ Theory of Disease. More recent developments, such as radiography, antibiotics, random clinical trial(RCT), and DNA sequencing, have further reshaped medicine to its modern form, which aims to provide precision management for each individual patient. To date, modern medicine has made tremendous progress in eliminating or preventing infectious diseases (e.g. smallpox, cholera, Aids, tuberculosis), improving the capability of clinical treatment for difficult and severe diseases (e.g. cardiovascular disease, cerebrovascular disease), developing innovative surgical methods, targeted and immune cancer therapies, raising health standards and extending the human lifespan.

While we are pacing forward to a new era with cross-culture collisions, new challenges keep emerging as lifestyle and environment change. Neurodegenerative diseases, mental disorders, and genetic diseases are becoming increasingly prevalent and may replace traditional diseases to be the focus of future medicine. With the growing passion interest in the metaverse, artificial intelligence (AI) and AI-imbedded machine will play a more active role in diagnosis, treatment, and drug discovery. Artificial organs, Nanobionics, prosthesis, brain-machine interface, and gene therapy will keep benefiting human wellness. With advanced medicine and technology, humans will keep exploring the ultimate questions of life: What kinds of genomic editing can be used for humans? How can we eliminate cancers or even prevent all types of diseases? Can we stop ourselves from aging? Can human hibernate? Can we store someone’s mind and transfer it to other identities?

To embrace such an intriguing future, we, a group of young scientists with passion and dreams from all over the world, are gathering together to launch a new professional journal–The Innovation Medicine, a sister journal of the high-level journal The Innovation, aiming to provide a fair and open platform for the medical community to share their innovative and exciting advances in theory or practice. “Innovation” will be the ever-lasting theme that runs through the journal, and our journal will be dedicated to a) implementing the notion of a community with a shared future of mankind; b) advancing medicine and translational study; c) promoting the upgrading of people's livelihood; d) promoting international cooperation to conquer uncharted territory. It is always our priority to make any innovative voice from any corner of the world is heard, that every single spirit is treated equally, and that every effort pays off.

To this end, The Innovation Medicine has established a globalized Editorial Board that includes the best experts worldwide, a professional managing team with successful experience in running high-level academic journals, an art team to refine vision presentation, and an international team to promote the journal on multiple social media platforms. We will make every effort to ensure a fair evaluation, unbiased peer review, and fast publication.

With our sincere expectations, we look forward to the active participation of domestic and international doctors, scholars, industrialists, and government personnel. Together, with your support, The Innovation Medicine will become a cornerstone for better human wellness. To see the unseen and changed the unchanged.

For Authors

All submissions are initially evaluated in depth by the scientific editors. Papers that do not conform to the general criteria for publication will be returned to the authors without detailed review. Otherwise, manuscripts will be sent to at least two reviewers who have agreed in advance to assess the paper rapidly. The editors will make every effort to reach decisions on these papers within 3 weeks of the submission date. If revisions are a condition of publication, generally 4 weeks are allowed for revisions, and only one revised version of the paper is considered. Evaluations of conceptual advance and significance are made on the basis of the literature available on the day of final decision, not the day of submission. Accepted papers will be published online ahead of the issue as soon as possible and will appear in an issue within 2 months of acceptance. Any major changes after acceptance are subject to review and may delay publication.

Fast-Track Review
If circumstances so warrant, authors may request a fast-track review of a paper in the cover letter. At the editor’s discretion, a fast-track review will be undertaken to expedite manuscripts that deserve rapid review and publication. Such review would be completed in less than 1 week.


Editorial Policies
Manuscripts are considered with the understanding that no part of the work has been published previously in print or electronic format and that the paper is not under consideration by another publication or electronic medium. All in-press or submitted works pertinent to the manuscript under consideration(including those cited in the manuscript under consideration) must accompany the submission. Related manuscripts that have been submitted elsewhere during the period of revision must accompany revised manuscripts. Failure to provide copies of related manuscripts under consideration elsewhere may delay the review process and may be grounds for rejection.

  The Innovation Medicine | Cover  
Volume 1 Issue 1
Academic co-partner
Stay connected
Journal links
The Hong Kong Polytechnic University
First Affiliated Hospital of Anhui Medical University
Life Science£º
  Copyright © 2023 The Innovation Medicine All Rights Reserved